Correlation Between GlaxoSmithKline PLC and Beta ETF

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Beta ETF at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Beta ETF into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Beta ETF WIG20Short, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Beta ETF and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Beta ETF. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Beta ETF.

Diversification Opportunities for GlaxoSmithKline PLC and Beta ETF

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Beta is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Beta ETF WIG20Short in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta ETF WIG20Short and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Beta ETF. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta ETF WIG20Short has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Beta ETF go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Beta ETF

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Beta ETF. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.16 times less risky than Beta ETF. The stock trades about -0.31 of its potential returns per unit of risk. The Beta ETF WIG20Short is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  29,520  in Beta ETF WIG20Short on August 29, 2024 and sell it today you would earn a total of  800.00  from holding Beta ETF WIG20Short or generate 2.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy90.91%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Beta ETF WIG20Short

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Beta ETF WIG20Short 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta ETF WIG20Short are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Beta ETF may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Beta ETF Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Beta ETF

The main advantage of trading using opposite GlaxoSmithKline PLC and Beta ETF positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Beta ETF can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta ETF will offset losses from the drop in Beta ETF's long position.
The idea behind GlaxoSmithKline PLC ADR and Beta ETF WIG20Short pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine